vs

Side-by-side financial comparison of Datadog (DDOG) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $953.2M, roughly 1.5× Datadog). ResMed runs the higher net margin — 27.6% vs 4.9%, a 22.7% gap on every dollar of revenue. On growth, Datadog posted the faster year-over-year revenue change (29.2% vs 11.0%). Over the past eight quarters, Datadog's revenue compounded faster (24.9% CAGR vs 7.9%).

Datadog, Inc. is an American company that provides an observability service for cloud-scale applications, providing monitoring of servers, databases, tools, and services, through a SaaS-based data analytics platform. Founded and headquartered in New York City, the company is a publicly traded entity on the Nasdaq stock exchange.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

DDOG vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.5× larger
RMD
$1.4B
$953.2M
DDOG
Growing faster (revenue YoY)
DDOG
DDOG
+18.2% gap
DDOG
29.2%
11.0%
RMD
Higher net margin
RMD
RMD
22.7% more per $
RMD
27.6%
4.9%
DDOG
Faster 2-yr revenue CAGR
DDOG
DDOG
Annualised
DDOG
24.9%
7.9%
RMD

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
DDOG
DDOG
RMD
RMD
Revenue
$953.2M
$1.4B
Net Profit
$46.6M
$392.6M
Gross Margin
80.4%
61.8%
Operating Margin
1.0%
34.6%
Net Margin
4.9%
27.6%
Revenue YoY
29.2%
11.0%
Net Profit YoY
2.1%
13.9%
EPS (diluted)
$0.13
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DDOG
DDOG
RMD
RMD
Q2 26
$1.4B
Q4 25
$953.2M
$1.4B
Q3 25
$885.7M
$1.3B
Q2 25
$826.8M
$1.3B
Q1 25
$761.6M
$1.3B
Q4 24
$737.7M
$1.3B
Q3 24
$690.0M
$1.2B
Q2 24
$645.3M
$1.2B
Net Profit
DDOG
DDOG
RMD
RMD
Q2 26
$392.6M
Q4 25
$46.6M
$392.6M
Q3 25
$33.9M
$348.5M
Q2 25
$2.6M
$379.7M
Q1 25
$24.6M
$365.0M
Q4 24
$45.6M
$344.6M
Q3 24
$51.7M
$311.4M
Q2 24
$43.8M
$292.2M
Gross Margin
DDOG
DDOG
RMD
RMD
Q2 26
61.8%
Q4 25
80.4%
61.8%
Q3 25
80.1%
61.5%
Q2 25
79.9%
60.8%
Q1 25
79.3%
59.3%
Q4 24
80.5%
58.6%
Q3 24
80.0%
58.6%
Q2 24
80.9%
58.5%
Operating Margin
DDOG
DDOG
RMD
RMD
Q2 26
34.6%
Q4 25
1.0%
34.6%
Q3 25
-0.7%
33.4%
Q2 25
-4.3%
33.7%
Q1 25
-1.6%
33.0%
Q4 24
1.3%
32.5%
Q3 24
2.9%
31.6%
Q2 24
2.0%
31.2%
Net Margin
DDOG
DDOG
RMD
RMD
Q2 26
27.6%
Q4 25
4.9%
27.6%
Q3 25
3.8%
26.1%
Q2 25
0.3%
28.2%
Q1 25
3.2%
28.3%
Q4 24
6.2%
26.9%
Q3 24
7.5%
25.4%
Q2 24
6.8%
23.9%
EPS (diluted)
DDOG
DDOG
RMD
RMD
Q2 26
$2.68
Q4 25
$0.13
$2.68
Q3 25
$0.10
$2.37
Q2 25
$0.01
$2.58
Q1 25
$0.07
$2.48
Q4 24
$0.14
$2.34
Q3 24
$0.14
$2.11
Q2 24
$0.12
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DDOG
DDOG
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$401.3M
$1.4B
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$3.7B
$6.3B
Total Assets
$6.6B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DDOG
DDOG
RMD
RMD
Q2 26
$1.4B
Q4 25
$401.3M
$1.4B
Q3 25
$540.6M
$1.4B
Q2 25
$489.0M
$1.2B
Q1 25
$1.1B
$932.7M
Q4 24
$1.2B
$521.9M
Q3 24
$337.4M
$426.4M
Q2 24
$411.0M
$238.4M
Total Debt
DDOG
DDOG
RMD
RMD
Q2 26
$663.8M
Q4 25
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$662.9M
Q3 24
$667.6M
Q2 24
$697.3M
Stockholders' Equity
DDOG
DDOG
RMD
RMD
Q2 26
$6.3B
Q4 25
$3.7B
$6.3B
Q3 25
$3.4B
$6.1B
Q2 25
$3.2B
$6.0B
Q1 25
$2.9B
$5.5B
Q4 24
$2.7B
$5.3B
Q3 24
$2.6B
$5.2B
Q2 24
$2.4B
$4.9B
Total Assets
DDOG
DDOG
RMD
RMD
Q2 26
$8.5B
Q4 25
$6.6B
$8.5B
Q3 25
$6.1B
$8.3B
Q2 25
$5.8B
$8.2B
Q1 25
$6.0B
$7.6B
Q4 24
$5.8B
$7.1B
Q3 24
$4.6B
$7.2B
Q2 24
$4.4B
$6.9B
Debt / Equity
DDOG
DDOG
RMD
RMD
Q2 26
0.11×
Q4 25
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.13×
Q3 24
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DDOG
DDOG
RMD
RMD
Operating Cash FlowLast quarter
$327.1M
Free Cash FlowOCF − Capex
$318.2M
FCF MarginFCF / Revenue
33.4%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
7.02×
TTM Free Cash FlowTrailing 4 quarters
$1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DDOG
DDOG
RMD
RMD
Q2 26
Q4 25
$327.1M
$339.7M
Q3 25
$251.5M
$457.3M
Q2 25
$200.1M
$538.8M
Q1 25
$271.5M
$578.7M
Q4 24
$265.2M
$308.6M
Q3 24
$228.7M
$325.5M
Q2 24
$164.4M
$440.1M
Free Cash Flow
DDOG
DDOG
RMD
RMD
Q2 26
Q4 25
$318.2M
$311.2M
Q3 25
$234.7M
$414.4M
Q2 25
$184.9M
$508.2M
Q1 25
$262.8M
$557.9M
Q4 24
$257.5M
$288.0M
Q3 24
$220.3M
$307.7M
Q2 24
$160.0M
$415.2M
FCF Margin
DDOG
DDOG
RMD
RMD
Q2 26
Q4 25
33.4%
21.9%
Q3 25
26.5%
31.0%
Q2 25
22.4%
37.7%
Q1 25
34.5%
43.2%
Q4 24
34.9%
22.5%
Q3 24
31.9%
25.1%
Q2 24
24.8%
33.9%
Capex Intensity
DDOG
DDOG
RMD
RMD
Q2 26
Q4 25
0.9%
2.0%
Q3 25
1.9%
3.2%
Q2 25
1.8%
2.3%
Q1 25
1.1%
1.6%
Q4 24
1.1%
1.6%
Q3 24
1.2%
1.5%
Q2 24
0.7%
2.0%
Cash Conversion
DDOG
DDOG
RMD
RMD
Q2 26
Q4 25
7.02×
0.87×
Q3 25
7.42×
1.31×
Q2 25
75.58×
1.42×
Q1 25
11.02×
1.59×
Q4 24
5.82×
0.90×
Q3 24
4.42×
1.05×
Q2 24
3.75×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DDOG
DDOG

North America$678.7M71%
International$274.5M29%

RMD
RMD

Segment breakdown not available.

Related Comparisons